← All companies
Monte Rosa Therapeutics, Inc.
GLUE - CIK 0001826457
Market cap$1.39 B
Rank#2396
SEC filings352
The table below shows Monte Rosa Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $159.86M | $208.34M | $69.43M | $78.53M | $125.58M | $108.85M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | $9.00M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.